Prof Andrew Price (Oxford)
|Funder name / reference number:||NHS England and Arthritis Research UK (Ref: 205180)|
|UKCRN Study portfolio:||IRAS 174593|
|Year||2013 - 2016|
Developing, piloting and testing the musculoskeletal health questionnaire (MSK-HQ): for use across musculoskeletal pathways
Phase 1 is completed and successfully developed a candidate MSK-HQ with 14 items capturing outcomes such as pain, function, sleep, physical activity and psychological impact.
Phase 2 to validate the MSK-HQ psychometric properties was completed in April 2016 in three clinical settings: people referred for orthopaedic surgery, individuals receiving treatment from community physiotherapy, and rheumatology outpatients with early inflammatory arthritis.
A fourth arm of the project used qualitative methods to understand how managerial and commissioning decisions are influenced by the availability of MSK-HQ outcomes data in one Clinical Commissioning Group.
This research aims to provide patients and clinicians across the musculoskeletal pathway with a practical tool for quantifying and monitoring the impact from musculoskeletal symptoms on an individual.